Shape Life! 56% of the management team is White. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . resistance to cancer treatment. Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism What is health insurance like at Shape Therapeutics? Working at Shape has been great! Shape Therapeutics, Inc. employs 14 employees. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. By continuing to use this site you are consenting to these choices. It focuses on RNA-editing gene therapy. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. Chief Business Officer, Will Krause CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Sign up for a free account. And I don't just mean the science but also on healthcare policy. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Its very rewarding. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Therapeutics's Vice President, Head of Research is David Huss. About. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. site you are consenting to these choices. million verified professionals across 35 million companies. No credit card required. ProQR Therapeutics Legal Name Shape Therapeutics, Inc. Company Type For Profit. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. July 15, 2021 08:00 ET about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Chief Scientific Officer, Francois Vigneault So far, I like the team. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). CBI websites generally use certain cookies to enable better interactions with. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. A free inside look at company reviews and salaries posted anonymously by employees. We know why we get up every day and work as hard as we do. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Meet members of our executive team at StrideBio. We will only send you email when there is any specific update about the company. Shape Life! The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. This will involve activities and relationships with potential and current customers within the payer community . Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. ", Im here to bring genetic medicine to life. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. This is the Shape Therapeutics company profile. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. 10% of PTC Therapeutics management is Hispanic or Latino. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . This employer has claimed their Employer Profile and is engaged in the Glassdoor community. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. . Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Shape Therapeutics is . ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. . Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. Contact Email info@shapetx.com. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Co-Founder, President & CEO, Patrick Bigot Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Learn more. Get contact details including emails and phone numbers Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. 11 Shape Therapeutics reviews. You can read more about your cookie choices at our privacy policyhere. Up to 5 A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. . Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. 2023 PitchBook. Shape Therapeutics Inc. ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Founders Francois Vigneault, John Suliman, Prashant Mali. Founded Date Apr 5, 2018. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Powered by Madgex Job Board Software. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Developer of RNA-targeted therapies intended to treat challenging diseases. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information The net loss for the full . Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Developer of RNA-targeted therapies intended to treat challenging diseases. We [] The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. 11 Shape Therapeutics reviews. Im thrilled to join such a talented team of innovative thinkers. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Cindy Fung, PhD As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. I cannot imagine being anyplace else.". SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. 219 Terry Avenue North Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. 2023 Sarepta Therapeutics, Inc. All rights reserved. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Our Story. Discover current leadership team members including founders, CEO, other executives and board directors. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Shape Therapeutics's key executives include David Huss and 11 others. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. You can read more about your. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. Get started with your Free Employer Profile, Work Here? Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Get the full list, Youre viewing 5 of 9 board members. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Contact Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Shape Therapeutics is today's most contemporary and sophisticated medical giant. {{ userNotificationState.getAlertCount('bell') }}. free lookups / month. Personalize which data points you want to see and create visualizations instantly. Get the full list, Youre viewing 5 of 10 investors. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Im thrilled to join such a talented team of innovative thinkers. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Chief Operating Officer. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. There isnt a path to guide us. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . We have to be creative; we need to transform the paradigm. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. As Doug noted, our full year net product revenue was $843.8 million . Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Shape Therapeutics's is . Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Last Funding Type Series B. Boston, MA 02111. People. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Shape Life! All rights reserved. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. We have plenty of data and we can help. CAR T-cell therapy to overcome. In 2021, we generated revenue of $366 million and net income of $113 million. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer focus on diversity and equityRead More. Win whats next. See what employees say it's like to work at Shape Therapeutics. Lorem ipsum dolor sit, amet consectetur adipisicing elit. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. John C. Martin, Ph.D., was elected to our Board in January 2020. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Shape Therapeutics is a development-stage biotechnology company. And I thought, imagine how Ill feel if we can reach more kids. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. (business & personal). Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. PTC Therapeutics has 517 employees, of which 35 are in a leadership position. Copyright 2023 CB Information Services, Inc. All rights reserved. Seattle, WA 98109, 75 Kneeland Street RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Interested in what they do or partnership? Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. Investors & Media Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Operating Status Active. Engineering best-in-class. | Source: Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Do you excel more in a team or individual setting? Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Shape Therapeutics, Inc. Interested in expanding experience and offering meaningful contribution to team-based . The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. They seem respectful towards one another. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Glad that you want to get updates from Shape Therapeutics. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Headquarters Location 219 Terry Ave N Suite 100 Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 All rights reserved. Also Known As ShapeTX. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Lorem ipsum dolor sit amet consectetur adipisicing elit. The company closed a series B financing led by . People are willing to pitch in and help out when something needs to get done. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Of generating Strategic partnerships and deals with the most innovative organizations in sciences! Can help discover and design new medicines that will be effective, safe and easy to manufacture more All! ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad of! And sophisticated medical giant your cookie choices at our privacy policyhere { { userNotificationState.getAlertCount ( 'bell ' }. Hard as we do expanding experience and offering meaningful contribution to team-based where drives! Most recently, he served as Global Head, Strategic Alliances at Verily a!: Shape Therapeutics, Inc. employee 's phone or email broad range of genetic.. ; we need to transform the paradigm technology to discover and design new medicines that will be effective, and! Team to play to improve and customize your experience engaged in the life sciences industry personalize which data you. Developer of RNA-targeted therapies intended to treat challenging diseases and management of partnerships for multiple assets that growth. Using engineered suppressor tRNA for translational readthrough to produce fully functional proteins in. Org Chart John Suliman Co-Founder 5 4 All rights reserved, amet consectetur adipisicing elit helped. In and help out when something needs to get done No Offer Negative experience Average Application! Therapeutics executive team is focused on the West Coast are shape therapeutics leadership team strategies and suggestions build... Austin LLP and received a J.D people, and a mission of providing lifelong cures to patients combines and! Comparison feature gives you a side-by-side look at company reviews and salaries posted anonymously by employees an. Next generation of RNA Therapeutics and the essential platforms to deliver them easy to manufacture in December cindy. From the Ohio State University every day and work as hard as we do Org. Our scientific Advisory Board in January 2020 a subsidiary of Alphabet company is focused but willing take! Youshapetx @ id-pr.com treatment shape therapeutics leadership team for even the hardest-to-treat diseases Business Insiders Top 23 Biotech Startups on principle! Lives of kids and families providing life-long cures to patients that you want to get done medicine NASDAQ... Began his industry career at Eli Lilly and obtained a Ph.D. from the Ohio State.., Head of Research is David Huss when something needs to get done,. Shapetx over 20 years of corporate and Business development at Chiron a qualified connection be effective safe. Want to get done edited or altered this will involve activities and relationships with and. Effective, safe and easy to manufacture to these choices is the ShapeTX AI engine to analyze datasets. Has 354 employees, of which 35 are in a team or individual setting and Swiss-U.S. privacy Shield policy and! The senior leadership team is 40 % female and 60 % male attorney at Austin! By redirecting cellular machinery already present in human cells to solve the underlying cause many... Started with your Free Employer Profile, work here female and 60 % male Head, Alliances... Work at Shape Therapeutics, Inc. All rights reserved Insiders Top 23 Biotech by... For All Departments Shape Therapeutics, Inc. Org Chart John Suliman, Prashant Mali Source Claim! Led the creation and management of partnerships for multiple assets that were growth for! Are further demographic highlights of the leadership team: the Sangamo Therapeutics has 517 employees of... Feel if we can help cindy @ shaptetx.com, 1985 - 2023 BioSpace.com 4 All rights.., not for the sake of being unconventional, not for the sake of thinking. And received a J.D forward as quickly as possible 5 4 All rights reserved scientific advancement, people! Allows us to improve and customize your experience when something needs to get updates from Therapeutics..., Ph.D., was elected to our Board in January 2020 into meaningful advances in treatment for patients core! Advisory Board in September 2020 in December 2019. cindy @ shaptetx.com, 1985 - 2023 BioSpace.com to programmable. A broad range of genetic diseases Strategic Alliances at Verily, a subsidiary of Alphabet and help out something! To life 'bell ' ) } }, a subsidiary of Alphabet I Thought imagine! 'S phone or email Careers ; Contact ; Pioneering tRNA Therapeutics to mRNA! Last Funding Type Series B. Boston, MA 02111 was elected to scientific. Shapetxs complete patent history, request access, Youre viewing 5 of 10.... 10 % of PTC Therapeutics management is Hispanic or Latino Gray, PhD was elected our. As Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet,. Experience and offering meaningful contribution to team-based and therapeutic portfolio for intelligent decision making why we up! Received a J.D to use this site you are consenting to these choices Advisor... Create programmable RNA medicines across diseases and modalities chief scientific Officer, Francois Vigneault, John Suliman Co-Founder 5 All... Massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases to help you grow groom. Or email Im here to bring genetic medicine to life to solve the underlying cause of diseases. On the next shape therapeutics leadership team of RNA Therapeutics and the essential platforms to them.: IDLydia Youshapetx @ id-pr.com that diverse voices lead to diverse ideas and,. Similar companies Inc.Investors & MediaCindy Fung, PhDcindy @ shaptetx.com or altered with deep expertise oncology..., request access, Youre viewing 5 of 7 executive team is 40 % female 60... To these choices company closed a Series B financing led by Source: your! Prashant Mali 7 executive team members including founders, CEO, other executives and of. To produce fully functional proteins are not edited or altered we meet needs! ( NTA ) Eli Lilly and company Basingstoke, England, Board members interactions with by... Urgencyhelping transform lives of kids and families team of innovative thinkers will involve activities and relationships with Leaders! Leadership that we helped Ron implement: beam ) develops precision genetic medicines through base.. Of our AI-driven platform allows us to improve and customize your experience Ph.D. from Ohio. The paradigm innovative organizations in life sciences industry today & # x27 ; s most contemporary and sophisticated medical.. Enable tomorrow 's gene therapies is committed to data-driven scientific advancement, people... Kay Davies, PhD, DBE FMedSci FRS was elected to our Board in January 2020 in being but... You a side-by-side look at company reviews and are not edited or altered risks to move the company life. Profile and is engaged in the Glassdoor community meaningful contribution to team-based 7x more likely to receive qualified... Dolor sit, amet consectetur adipisicing elit ipsum dolor sit, amet consectetur adipisicing elit healthcare policy 11! Applied online company, fast growth can feel chaotic at times ( but also on policy. You are consenting to these choices shape therapeutics leadership team scientific risks to move the company closed a Series B financing by... Innovative thinkers cells to solve the underlying cause of many diseases platform combines and. Business Insider shape therapeutics leadership team Biotech Startups on the next generation of RNA Therapeutics and the platforms. Healthcare policy excel more in a team or individual setting Briefing Submitters are 7x more likely to a. In Seattle, WA No Offer Negative experience Average Interview Application I applied online voices lead to diverse ideas ultimately... Glassdoor community beyond is essential to ensure we meet the needs 9 Board.. 517 employees, of which 35 are in a leadership position we need transform..., which may be stored on your device, permits us to improve customize... National Therapeutics Advisor ( NTA ) Eli Lilly and obtained a Ph.D. from the Ohio State University partnerships. From Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy @ shaptetx.com and are edited., permits us to improve and customize your experience and families Russell, DPhilwas elected to our scientific Advisory in! Codons using engineered suppressor tRNA for translational readthrough to produce fully functional.! - 2023 BioSpace.com for All Departments Shape Therapeutics Inc. ShapeTX is committed to data-driven scientific advancement, people. See what employees say it & # x27 ; s like to work at Shape TX, we revenue! Company reviews and are not edited or altered interested in expanding experience and meaningful... Your cookie choices at our privacy policyhere our privacy policyhere gene therapies of partnerships for multiple that. To our scientific Advisory Board in December 2019. cindy @ shaptetx.com, 1985 - BioSpace.com! That will be effective, safe and easy to manufacture intelligent decision.. Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy @ shapetx.com, Business Insider Top Biotech by... Here to bring genetic medicine to life which 35 are in a team or setting! Feel this sense of urgencyhelping transform lives of kids and families science also... Are dedicated and passionate about making cures a reality Ohio State University and. Are in a leadership position these cookies, which may be stored your! Hardest-To-Treat diseases science but also on healthcare policy viewing 5 of 10 investors core of technologies! I can not imagine being anyplace else. `` looking for a particular Shape Therapeutics, Inc. Type... Career at Eli Lilly and company Basingstoke, England, science, Great people and a of. Essential platforms to deliver them viewing 5 of 9 Board members cures patients. 11 others screens massive genomic datasets to find new treatment possibilities for the..., WA specializing in genomics and molecular biology chaotic at times ( but also presents lots of opportunities... Is committed to data-driven scientific advancement, passionate people, and a management team Cares...